Skip to main content
Signal8

Madigan Catherine

SEC insider (Form 3/4/5 filer). CIK 0001914577. Chief Medical Officer at Hemab Therapeutics Holdings, Inc. (COAG). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 30, 2026. Located in CAMBRIDGE, MA.

Companies Madigan Catherine has filed insider reports for

  • Hemab Therapeutics Holdings, Inc. (COAG): Officer, Chief Medical Officer
Madigan Catherine profile photo

Madigan Catherine

CIK: 0001914577

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Hemab Therapeutics Holdings, Inc. logo
COAG

Hemab Therapeutics Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Hemab Therapeutics Holdings, Inc. logo
    COAG

    Hemab Therapeutics Holdings, Inc.

    Apr 30, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    49K shares-
  • Hemab Therapeutics Holdings, Inc. logo
    COAG

    Hemab Therapeutics Holdings, Inc.

    Jan 29, 2026
    Award

    Warrants (Right to Buy)

    Direct
    145.1K shares-

1-2 of 2